James H. Laird

Radiation Oncology

230 Waterford Parkway S
Waterford, CT 06385

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Consolidative Radiotherapy for Extensive-Stage Small Cell Lung Cancer: Outcomes Based on Completeness of Consolidation and Oligometastatic State.

Consolidative Radiotherapy for Extensive-Stage Small Cell Lung Cancer: Outcomes Based on Completeness of Consolidation and Oligometastatic State.

Journal: Clinical lung cancer

Published: November 11, 2025

Association of Immunogenicity and Drug Exposure and the Importance of Target Engagement in ADA Development: A Clinical Case Study of Anti-SARS-CoV-2 Biotherapeutics.

Association of Immunogenicity and Drug Exposure and the Importance of Target Engagement in ADA Development: A Clinical Case Study of Anti-SARS-CoV-2 Biotherapeutics.

Journal: The AAPS journal

Published: June 06, 2025

Dose-Volume Predictors of Radiation Pneumonitis After Thoracic Hypofractionated Radiation Therapy.

Dose-Volume Predictors of Radiation Pneumonitis After Thoracic Hypofractionated Radiation Therapy.

Journal: Practical radiation oncology

Published: September 24, 2023

Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiation Therapy.

Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiation Therapy.

Journal: Advances in radiation oncology

Published: July 12, 2023

Radiation Recall Dermatitis After Capecitabine in a Patient With Triple Negative Breast Cancer.

Radiation Recall Dermatitis After Capecitabine in a Patient With Triple Negative Breast Cancer.

Journal: Practical radiation oncology

Published: May 13, 2021

Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other Specialties.

Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other Specialties.

Journal: International journal of radiation oncology, biology, physics

Published: October 06, 2020

Positron-Emission Tomographic Imaging of a Fluorine 18-Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient-Derived Xenografts.

Positron-Emission Tomographic Imaging of a Fluorine 18-Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient-Derived Xenografts.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: April 12, 2019

ASO Author Reflections: Breast Cancer Local Recurrence Versus New Primary-Clinical Predictors and Prognostic Implications.

ASO Author Reflections: Breast Cancer Local Recurrence Versus New Primary-Clinical Predictors and Prognostic Implications.

Journal: Annals of surgical oncology

Published: September 30, 2018

Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies.

Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies.

Journal: Cancer medicine

Published: March 27, 2018

Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts.

Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 09, 2018

Reply to "Questions About In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy".

Reply to "Questions About In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy".

Journal: Annals of surgical oncology

Published: November 20, 2017

Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.

Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.

Journal: Annals of surgical oncology

Published: August 22, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026